Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
YSB Inc. ( (HK:9885) ) just unveiled an update.
YSB Inc. has entered into a strategic cooperation and business deployment agreement with Shenzhen DOBOT Corp Ltd to explore the application of collaborative robots (cobots) and AI products in pharmaceutical R&D, warehousing, and medication services. This partnership aims to integrate robotics with the pharmaceutical industry, enhancing technology development and societal health. The initial phase involves deploying cobots in pharmacies and warehousing, with DOBOT producing the robots and YSB Inc. handling sales within the pharmaceutical sector. This collaboration is expected to drive innovation and resource integration, leveraging the strengths of both companies.
More about YSB Inc.
YSB Inc., founded in 2015, operates in the pharmaceutical industry, focusing on the outside-of-hospital pharmaceutical market and primary healthcare sector. The company provides digital and intelligent solutions to pharmacies and healthcare institutions, aiming to empower enterprises across the pharmaceutical industry’s supply chain.
Average Trading Volume: 6,450,260
Technical Sentiment Signal: Hold
For an in-depth examination of 9885 stock, go to TipRanks’ Stock Analysis page.